This week’s CMC forum looks at the race to develop multi-million-dollar cell and gene therapies in Central Ohio. 

Central Ohio is rapidly becoming a key player in cell and gene therapy, promising to turn the state into a Silicon Valley for this cutting-edge medical technology.   

Cell and gene therapy are related fields that share the goal of modifying genetic material to fight diseases or to improve the way the body functions. The potential is enormous, both in patient outcomes and investor profit.     

This CMC forum was recorded live on March 16, 2022.  

The panelists are: 

Samantha M. Jaglowski, MD, Physician and Associate Professor-Clinical in Leukemia Research, The James Comprehensive Cancer Center, The Ohio State University  

Timothy J. Miller, Ph.D., CEO, President, and Co-Founder, Forge Biologics 

Eli Phillips Jr., PharmD, Vice President for Specialty Solutions, Cardinal Health 

The host is Eddie Pauline, President and CEO of BioOhio. 

CMC’s Optimal Health Series is presented by the Ohio State University Wexner Medical Center and by Nationwide Children's Hospital. This forum was sponsored by Cardinal Health, BioOhio, Armatus Bio, Andelyn Biosciences, and by JobsOhio